| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/22/2010 | US20100099707 Method for treating pulmonary arterial hypertension |
| 04/22/2010 | US20100099706 Argatroban formulation |
| 04/22/2010 | US20100099705 Argatroban formulation |
| 04/22/2010 | US20100099704 Lotion Preparation Containing Pyridonecarboxylic Acid Derivative |
| 04/22/2010 | US20100099703 Phenylamino-substituted piperidine compounds, their preparation and use as medicaments |
| 04/22/2010 | US20100099702 Therapeutic agent for neuropathic pain |
| 04/22/2010 | US20100099701 Isoquinolinone modulators of 5-ht3 receptors |
| 04/22/2010 | US20100099700 Hydrogenated pyrido (4,3-b) indoles for treating amyotrophic lateral sclerosis (als) |
| 04/22/2010 | US20100099699 Peripheral opioid receptor antagonists and uses thereof |
| 04/22/2010 | US20100099697 Method of Treatment Using Inhibitors of Mitosis |
| 04/22/2010 | US20100099696 Tamper resistant oral dosage forms containing an embolizing agent |
| 04/22/2010 | US20100099695 HCV NS3 Protease Inhibitors |
| 04/22/2010 | US20100099694 2-anilino-4-heteroaryl pyrimidine derivatives, and preparation thereof as medicaments, pharmaceutical compositions, and in particular ikk inhibitors |
| 04/22/2010 | US20100099693 New combination for use in the treatment of inflammatory disorders |
| 04/22/2010 | US20100099691 Pyrimidinyl pyridone inhibitors of jnk |
| 04/22/2010 | US20100099690 Xanthine derivatives as selective hm74a agonists |
| 04/22/2010 | US20100099689 Methods of modulating ppar gamma-type receptors |
| 04/22/2010 | US20100099688 Novel phosphodiesterase inhibitors |
| 04/22/2010 | US20100099687 Tadalafil solid composites |
| 04/22/2010 | US20100099686 Compounds useful as protein kinase inhibitors |
| 04/22/2010 | US20100099685 Crystalline forms of (6r)-l-erythro-tetrahydrobiopterin dihydrochloride |
| 04/22/2010 | US20100099684 Quinuclidine Compounds as Alpha-7 Nicotinic Acetylcholine Receptor Ligands |
| 04/22/2010 | US20100099683 Compounds that inhibit human dna ligases and methods of treating cancer |
| 04/22/2010 | US20100099682 Acetylene derivatives |
| 04/22/2010 | US20100099681 Substituted 5-aminopyrazoles and use thereof |
| 04/22/2010 | US20100099680 Pteridinone derivatives as p13-kinases inhibitors |
| 04/22/2010 | US20100099679 FUSED BICYCLIC mTOR INHIBITORS |
| 04/22/2010 | US20100099678 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders |
| 04/22/2010 | US20100099677 Compounds, Compositions and Methods Comprising Thiazole Derivatives |
| 04/22/2010 | US20100099676 Sulfonylurea derivative capable of selectively inhibiting mmp-13 |
| 04/22/2010 | US20100099675 Novel pyrrole derivative having ureido group and aminocarbonyl group as substituents |
| 04/22/2010 | US20100099674 Method and means for preventing and inhibiting type iii secretion in infections caused by gram-negative bacteria |
| 04/22/2010 | US20100099673 Decahydroquinoline analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| 04/22/2010 | US20100099672 Methods for treating hepatitis c |
| 04/22/2010 | US20100099671 Glucokinase activator |
| 04/22/2010 | US20100099670 Benzoquinazoline derivatives |
| 04/22/2010 | US20100099669 Dopamine 3 receptor agonist and antagonist treatment of gastrointestinal motility disorders |
| 04/22/2010 | US20100099668 Local topical administration formulations containing indoxacarb |
| 04/22/2010 | US20100099667 Bridged heterocyclic compounds and methods of use |
| 04/22/2010 | US20100099666 Phenothiazine modulators of h1 receptor and d2 receptor |
| 04/22/2010 | US20100099665 Isoquinolinone derivatives |
| 04/22/2010 | US20100099664 Substituted pyrrolidine amides, the production thereof, and the use thereof as medications |
| 04/22/2010 | US20100099663 4-trifluoromethoxyphenoxybenzol-4'-sulfonic acids, method for the production and use thereof in medicaments |
| 04/22/2010 | US20100099662 Hydrazone derivative |
| 04/22/2010 | US20100099661 Antibacterial aminoglycoside analogs |
| 04/22/2010 | US20100099660 Method for treating thrombosis or embolism and related diseases |
| 04/22/2010 | US20100099659 Inhibitors of Bruton's Tyrosine Kinase |
| 04/22/2010 | US20100099658 Di(arylamino)aryl compound |
| 04/22/2010 | US20100099657 Diphenylazetidinone Derivatives Possessing Cholesterol Absorption Inhibitory Activity |
| 04/22/2010 | US20100099656 Neurotherapeutic compositions |
| 04/22/2010 | US20100099655 Implants and methods for treating inflammation-mediated conditions of the eye |
| 04/22/2010 | US20100099654 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents |
| 04/22/2010 | US20100099653 Particle Size Reduction Apparatus, and Use Thereof |
| 04/22/2010 | US20100099652 Novel composition based on cholest-4-en-3-one oxime |
| 04/22/2010 | US20100099651 Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders |
| 04/22/2010 | US20100099650 Nasal spray composition and method for treating rhinitis, sinusitis or both |
| 04/22/2010 | US20100099649 Site-specific chemical modification of proteins at their n-termini, enabling the formation of homogeneous adducts |
| 04/22/2010 | US20100099648 Natural equivalent of chemically modified starch |
| 04/22/2010 | US20100099647 Aqueous Iron Carbohydrate Complexes, Their Production And Medicaments Containing Them |
| 04/22/2010 | US20100099645 Compositions containing pufa and methods of use thereof |
| 04/22/2010 | US20100099643 Fused Pentacyclic Polyethers |
| 04/22/2010 | US20100099642 Tgf-beta stimulant and further agent to reduce side effects |
| 04/22/2010 | US20100099641 Crystalline form of 1-choloro-4-(beta-d-glucopyranos-1-yl)-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments |
| 04/22/2010 | US20100099640 Tissue degeneration protection |
| 04/22/2010 | US20100099639 W/o/w emulsion composition |
| 04/22/2010 | US20100099638 Immunocompetent xenograft model |
| 04/22/2010 | US20100099637 Use of cycloartane compounds for treating arthritis |
| 04/22/2010 | US20100099636 Hydrous gel and production process and use of the hydrous gel |
| 04/22/2010 | US20100099635 Method for treating cystic fibrosis |
| 04/22/2010 | US20100099634 Macrolide compounds endowed with antiinflammatory activity |
| 04/22/2010 | US20100099633 Method for enhancing nutrient absorption with astragalosides |
| 04/22/2010 | US20100099632 Oligosaccharide Aldonic Acids and Their Topical Use |
| 04/22/2010 | US20100099631 Novel Use |
| 04/22/2010 | US20100099630 Method for improving ventilatory efficiency |
| 04/22/2010 | US20100099628 Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue |
| 04/22/2010 | US20100099613 Peptides for inducing a ctl and/or htl response to hepatitis c virus |
| 04/22/2010 | US20100099606 Effective use method of medicaments and method of preventing expression of side effect |
| 04/22/2010 | US20100099106 Cell death inhibitor |
| 04/22/2010 | US20100098794 Topical anti-wrinkle and anti-aging moisturizing cream |
| 04/22/2010 | US20100098788 Extracts of Curcuma and Methods of Use Thereof |
| 04/22/2010 | US20100098786 Formulation containing a carboxylic acid or an ester thereof |
| 04/22/2010 | US20100098775 Detecting genetic predisposition to osteoarthritis associated conditions |
| 04/22/2010 | US20100098772 Drug delivery systems and methods for treating neovascularization |
| 04/22/2010 | US20100098771 Abuse-resistant oral dosage forms and method of use thereof |
| 04/22/2010 | US20100098770 Sirolimus pharmaceutical formulations |
| 04/22/2010 | US20100098766 Use of an aqueous micro-emulsion for the preparation of a formulation for the treatment of adipose diseases |
| 04/22/2010 | US20100098764 Polysaccharide gel formulation having multi-stage bioactive agent delivery |
| 04/22/2010 | US20100098763 Pharmaceutical formulation 514 |
| 04/22/2010 | US20100098759 Controlled-release preparation containing cilostazol and process for the preparation thereof |
| 04/22/2010 | US20100098758 Abuse-Resistant Dosage Form |
| 04/22/2010 | US20100098757 Process for production of buprenorphine pharmaceutical preparation to be applied to mouth mucosa |
| 04/22/2010 | US20100098756 Oral disintegrating tablet |
| 04/22/2010 | US20100098755 Process of producing directly compressed tablets of sterols and/or stanols |
| 04/22/2010 | US20100098753 Prophylactic and/or therapeutic agent for cardiac infarction |
| 04/22/2010 | US20100098752 Materials and Methods for Delivering Antioxidants into the Skin |
| 04/22/2010 | US20100098750 Pharmaceutical composition comprising phenylamidine derivative and method of using the pharmaceutical composition in combination with antifungal agent |
| 04/22/2010 | US20100098747 Percutaneous administration device of bisoprolol |
| 04/22/2010 | US20100098746 Compositions and methods for treating periodontal disease comprising clonidine, sulindac and/or fluocinolone |
| 04/22/2010 | US20100098744 Reduction of infection associated with medical device |
| 04/22/2010 | US20100098735 Injectable depot compositions and its process of preparation |